Policy & Regulation
30 March 2023 - Germany-based pharmaceutical company Boehringer Ingelheim reported on Wednesday a strong performance in 2022.The company stated that 2022 was a year in which 30 million patients benefi...
30 March 2023 - China-based genomic research organisation, BGI Genomics, announced on Wednesday the launch of COLOTECTTM 1.0 in Slovakia, in collaboration with its partner, Zentya, a Slovak-based comp...
30 March 2023 - ImmunoPrecise Antibodies Ltd (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, said on Thursday that its subsidiary Talem has entered into a research collabora...
29 March 2023 - Biotechnology company Regeneron Pharmaceuticals (NASDAQ:REGN) said on Wednesday that the European Commission has approved Libtayo (cemiplimab) in combination with platinum-based chemot...
29 March 2023 - Clinical-stage immuno-oncology company Affimed N.V. (Nasdaq:AFMD) reported on Wednesday that the first patient has been dosed in the first-in-human clinical trial of the innate cell en...
29 March 2023 - Cardiff Oncology, Inc. (Nasdaq: CRDF), a US-based clinical-stage biotechnology company, announced on Tuesday that it has dosed its first subject with its investigational drug onvansert...